Unknown

Dataset Information

0

Potential Antiviral Options against SARS-CoV-2 Infection.


ABSTRACT: As of June 2020, the number of people infected with severe acute respiratory coronavirus 2 (SARS-CoV-2) continues to skyrocket, with more than 6.7 million cases worldwide. Both the World Health Organization (WHO) and United Nations (UN) has highlighted the need for better control of SARS-CoV-2 infections. However, developing novel virus-specific vaccines, monoclonal antibodies and antiviral drugs against SARS-CoV-2 can be time-consuming and costly. Convalescent sera and safe-in-man broad-spectrum antivirals (BSAAs) are readily available treatment options. Here, we developed a neutralization assay using SARS-CoV-2 strain and Vero-E6 cells. We identified the most potent sera from recovered patients for the treatment of SARS-CoV-2-infected patients. We also screened 136 safe-in-man broad-spectrum antivirals against the SARS-CoV-2 infection in Vero-E6 cells and identified nelfinavir, salinomycin, amodiaquine, obatoclax, emetine and homoharringtonine. We found that a combination of orally available virus-directed nelfinavir and host-directed amodiaquine exhibited the highest synergy. Finally, we developed a website to disseminate the knowledge on available and emerging treatments of COVID-19.

SUBMITTER: Ianevski A 

PROVIDER: S-EPMC7354438 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


As of June 2020, the number of people infected with severe acute respiratory coronavirus 2 (SARS-CoV-2) continues to skyrocket, with more than 6.7 million cases worldwide. Both the World Health Organization (WHO) and United Nations (UN) has highlighted the need for better control of SARS-CoV-2 infections. However, developing novel virus-specific vaccines, monoclonal antibodies and antiviral drugs against SARS-CoV-2 can be time-consuming and costly. Convalescent sera and safe-in-man broad-spectru  ...[more]

Similar Datasets

| S-EPMC7393772 | biostudies-literature
| S-EPMC8435103 | biostudies-literature
| S-EPMC9531640 | biostudies-literature
| S-EPMC7671653 | biostudies-literature
| S-SCDT-10_1038-S44319-024-00189-4 | biostudies-other
| S-EPMC7754928 | biostudies-literature
| S-SCDT-10_15252-EMBR_202256374 | biostudies-other
| S-EPMC8587465 | biostudies-literature
| S-EPMC7404948 | biostudies-literature
| S-EPMC8401008 | biostudies-literature